Journal: Microbiology Spectrum
Article Title: Respiratory virus coinfections during the COVID-19 pandemic: epidemiologic analysis and clinical outcomes from the Phase 2/3 molnupiravir trial (MOVe-OUT)
doi: 10.1128/spectrum.03563-23
Figure Lengend Snippet: Number of non-SARS-CoV-2 respiratory pathogens detected at baseline (all randomized population). a One participant had a baseline RPP positive for human rhinovirus/enterovirus and influenza B. Nucleic acids from the following pathogens could be detected and identified by the NxTAG Respiratory Pathogen Panel for the Luminex MAGPIX instrument: adenovirus; coronavirus 229E, OC43, NL63, or HKU1; human bocavirus; human metapneumovirus; influenza A, A H1, A H3, or B; human parainfluenza virus 1, 2, 3, or 4; respiratory syncytial virus A or B; human rhinovirus/enterovirus; Chlamydophila pneumoniae ; and Mycoplasma pneumoniae .
Article Snippet: Among 1,735 total randomized participants, 1,674 had a baseline respiratory pathogen panel (NxTAG Respiratory Pathogen Panel for the Luminex MAGPIX instrument) performed and 69 (4.1%) were coinfected with at least one additional respiratory viral pathogen.
Techniques: Luminex, Virus